nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CA9—breast cancer	0.339	0.776	CbGaD
Indapamide—CYP3A4—breast cancer	0.0978	0.224	CbGaD
Indapamide—CYP3A4—Exemestane—breast cancer	0.0277	0.133	CbGbCtD
Indapamide—CYP3A4—Letrozole—breast cancer	0.0236	0.113	CbGbCtD
Indapamide—CYP3A4—Anastrozole—breast cancer	0.021	0.101	CbGbCtD
Indapamide—CYP3A4—Toremifene—breast cancer	0.0192	0.0921	CbGbCtD
Indapamide—CYP3A4—Fulvestrant—breast cancer	0.0179	0.0856	CbGbCtD
Indapamide—CYP3A4—Thiotepa—breast cancer	0.0159	0.0763	CbGbCtD
Indapamide—CYP3A4—Ixabepilone—breast cancer	0.0146	0.0698	CbGbCtD
Indapamide—CYP3A4—Lapatinib—breast cancer	0.014	0.0672	CbGbCtD
Indapamide—CYP3A4—Raloxifene—breast cancer	0.0106	0.0509	CbGbCtD
Indapamide—CYP3A4—Vinorelbine—breast cancer	0.00778	0.0373	CbGbCtD
Indapamide—CYP3A4—Tamoxifen—breast cancer	0.00702	0.0336	CbGbCtD
Indapamide—CYP3A4—Mitoxantrone—breast cancer	0.00685	0.0328	CbGbCtD
Indapamide—KCNE1—mammary gland—breast cancer	0.00595	0.139	CbGeAlD
Indapamide—CYP3A4—Paclitaxel—breast cancer	0.00547	0.0262	CbGbCtD
Indapamide—CYP3A4—Irinotecan—breast cancer	0.00539	0.0258	CbGbCtD
Indapamide—CYP3A4—Vinblastine—breast cancer	0.0048	0.023	CbGbCtD
Indapamide—CYP3A4—Docetaxel—breast cancer	0.00395	0.0189	CbGbCtD
Indapamide—CYP3A4—Doxorubicin—breast cancer	0.00295	0.0141	CbGbCtD
Indapamide—KCNE1—female reproductive system—breast cancer	0.00246	0.0573	CbGeAlD
Indapamide—KCNE1—endocrine gland—breast cancer	0.00208	0.0485	CbGeAlD
Indapamide—CA5A—female reproductive system—breast cancer	0.00187	0.0434	CbGeAlD
Indapamide—CA5B—mammary gland—breast cancer	0.00175	0.0407	CbGeAlD
Indapamide—CA5A—endocrine gland—breast cancer	0.00158	0.0368	CbGeAlD
Indapamide—KCNQ1—pituitary gland—breast cancer	0.00123	0.0287	CbGeAlD
Indapamide—KCNQ1—adipose tissue—breast cancer	0.00123	0.0286	CbGeAlD
Indapamide—SLC12A3—female reproductive system—breast cancer	0.00122	0.0283	CbGeAlD
Indapamide—KCNQ1—female reproductive system—breast cancer	0.00113	0.0263	CbGeAlD
Indapamide—KCNQ1—adrenal gland—breast cancer	0.0011	0.0257	CbGeAlD
Indapamide—CA9—female reproductive system—breast cancer	0.00109	0.0254	CbGeAlD
Indapamide—KCNQ1—bone marrow—breast cancer	0.00107	0.0248	CbGeAlD
Indapamide—KCNQ1—female gonad—breast cancer	0.00103	0.0239	CbGeAlD
Indapamide—CA4—nipple—breast cancer	0.000998	0.0232	CbGeAlD
Indapamide—KCNQ1—endocrine gland—breast cancer	0.000957	0.0223	CbGeAlD
Indapamide—CA9—endocrine gland—breast cancer	0.000922	0.0215	CbGeAlD
Indapamide—Furosemide—CA9—breast cancer	0.000913	0.235	CrCbGaD
Indapamide—Metolazone—CA9—breast cancer	0.000877	0.226	CrCbGaD
Indapamide—CA2—nipple—breast cancer	0.000828	0.0193	CbGeAlD
Indapamide—CA12—female reproductive system—breast cancer	0.000806	0.0188	CbGeAlD
Indapamide—CA5B—adipose tissue—breast cancer	0.000787	0.0183	CbGeAlD
Indapamide—CA5B—female reproductive system—breast cancer	0.000723	0.0168	CbGeAlD
Indapamide—CA5B—adrenal gland—breast cancer	0.000706	0.0164	CbGeAlD
Indapamide—Bumetanide—CA9—breast cancer	0.000692	0.178	CrCbGaD
Indapamide—CA2—embryo—breast cancer	0.000683	0.0159	CbGeAlD
Indapamide—CA12—endocrine gland—breast cancer	0.000682	0.0159	CbGeAlD
Indapamide—Chlorthalidone—CA9—breast cancer	0.000678	0.175	CrCbGaD
Indapamide—KCNQ1—lymph node—breast cancer	0.000661	0.0154	CbGeAlD
Indapamide—CA5B—endocrine gland—breast cancer	0.000612	0.0143	CbGeAlD
Indapamide—CA2—epithelium—breast cancer	0.000557	0.013	CbGeAlD
Indapamide—CA4—pituitary gland—breast cancer	0.000545	0.0127	CbGeAlD
Indapamide—CA4—adipose tissue—breast cancer	0.000543	0.0126	CbGeAlD
Indapamide—CA2—skin of body—breast cancer	0.00053	0.0123	CbGeAlD
Indapamide—CA4—female reproductive system—breast cancer	0.000499	0.0116	CbGeAlD
Indapamide—CA4—adrenal gland—breast cancer	0.000487	0.0113	CbGeAlD
Indapamide—CA4—bone marrow—breast cancer	0.000471	0.011	CbGeAlD
Indapamide—CA4—female gonad—breast cancer	0.000454	0.0106	CbGeAlD
Indapamide—CA2—pituitary gland—breast cancer	0.000452	0.0105	CbGeAlD
Indapamide—CA2—adipose tissue—breast cancer	0.00045	0.0105	CbGeAlD
Indapamide—CA5B—lymph node—breast cancer	0.000423	0.00985	CbGeAlD
Indapamide—CA4—endocrine gland—breast cancer	0.000422	0.00984	CbGeAlD
Indapamide—CA2—female reproductive system—breast cancer	0.000414	0.00964	CbGeAlD
Indapamide—CA2—adrenal gland—breast cancer	0.000404	0.00941	CbGeAlD
Indapamide—CA2—bone marrow—breast cancer	0.000391	0.0091	CbGeAlD
Indapamide—CA2—female gonad—breast cancer	0.000377	0.00877	CbGeAlD
Indapamide—CA2—endocrine gland—breast cancer	0.00035	0.00816	CbGeAlD
Indapamide—CA4—lymph node—breast cancer	0.000292	0.0068	CbGeAlD
Indapamide—CYP3A4—female reproductive system—breast cancer	0.000267	0.00622	CbGeAlD
Indapamide—CA2—lymph node—breast cancer	0.000242	0.00564	CbGeAlD
Indapamide—Furosemide—ALB—breast cancer	0.000229	0.0591	CrCbGaD
Indapamide—CYP3A4—endocrine gland—breast cancer	0.000226	0.00526	CbGeAlD
Indapamide—Bumetanide—PTGS2—breast cancer	0.000195	0.0503	CrCbGaD
Indapamide—Oxcarbazepine—CYP3A4—breast cancer	0.000158	0.0408	CrCbGaD
Indapamide—Oxcarbazepine—ALB—breast cancer	0.000138	0.0356	CrCbGaD
Indapamide—Cardiac disorder—Epirubicin—breast cancer	3.46e-05	0.000148	CcSEcCtD
Indapamide—Vomiting—Fluorouracil—breast cancer	3.46e-05	0.000148	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—breast cancer	3.46e-05	0.000148	CcSEcCtD
Indapamide—Dyspepsia—Docetaxel—breast cancer	3.46e-05	0.000148	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—breast cancer	3.45e-05	0.000148	CcSEcCtD
Indapamide—Insomnia—Capecitabine—breast cancer	3.44e-05	0.000147	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—breast cancer	3.43e-05	0.000147	CcSEcCtD
Indapamide—Rash—Fluorouracil—breast cancer	3.43e-05	0.000147	CcSEcCtD
Indapamide—Dermatitis—Fluorouracil—breast cancer	3.43e-05	0.000147	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—breast cancer	3.42e-05	0.000147	CcSEcCtD
Indapamide—Paraesthesia—Capecitabine—breast cancer	3.42e-05	0.000146	CcSEcCtD
Indapamide—Decreased appetite—Docetaxel—breast cancer	3.41e-05	0.000146	CcSEcCtD
Indapamide—Hypersensitivity—Paclitaxel—breast cancer	3.41e-05	0.000146	CcSEcCtD
Indapamide—Headache—Fluorouracil—breast cancer	3.41e-05	0.000146	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—breast cancer	3.41e-05	0.000146	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—breast cancer	3.4e-05	0.000146	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—breast cancer	3.4e-05	0.000146	CcSEcCtD
Indapamide—Gastrointestinal disorder—Docetaxel—breast cancer	3.39e-05	0.000145	CcSEcCtD
Indapamide—Dyspnoea—Capecitabine—breast cancer	3.39e-05	0.000145	CcSEcCtD
Indapamide—Fatigue—Docetaxel—breast cancer	3.39e-05	0.000145	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—breast cancer	3.38e-05	0.000145	CcSEcCtD
Indapamide—Nausea—Irinotecan—breast cancer	3.38e-05	0.000145	CcSEcCtD
Indapamide—Nausea—Mitoxantrone—breast cancer	3.38e-05	0.000145	CcSEcCtD
Indapamide—Constipation—Docetaxel—breast cancer	3.36e-05	0.000144	CcSEcCtD
Indapamide—Pain—Docetaxel—breast cancer	3.36e-05	0.000144	CcSEcCtD
Indapamide—Back pain—Methotrexate—breast cancer	3.36e-05	0.000144	CcSEcCtD
Indapamide—Dyspepsia—Capecitabine—breast cancer	3.35e-05	0.000143	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—breast cancer	3.33e-05	0.000143	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—breast cancer	3.33e-05	0.000142	CcSEcCtD
Indapamide—Asthenia—Paclitaxel—breast cancer	3.33e-05	0.000142	CcSEcCtD
Indapamide—Decreased appetite—Capecitabine—breast cancer	3.31e-05	0.000142	CcSEcCtD
Indapamide—Nausea—Gemcitabine—breast cancer	3.29e-05	0.000141	CcSEcCtD
Indapamide—Gastrointestinal disorder—Capecitabine—breast cancer	3.28e-05	0.000141	CcSEcCtD
Indapamide—Fatigue—Capecitabine—breast cancer	3.28e-05	0.00014	CcSEcCtD
Indapamide—Pruritus—Paclitaxel—breast cancer	3.28e-05	0.00014	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—breast cancer	3.27e-05	0.00014	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—breast cancer	3.26e-05	0.00014	CcSEcCtD
Indapamide—Constipation—Capecitabine—breast cancer	3.25e-05	0.000139	CcSEcCtD
Indapamide—Pain—Capecitabine—breast cancer	3.25e-05	0.000139	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—breast cancer	3.25e-05	0.000139	CcSEcCtD
Indapamide—Erythema—Epirubicin—breast cancer	3.25e-05	0.000139	CcSEcCtD
Indapamide—Feeling abnormal—Docetaxel—breast cancer	3.24e-05	0.000139	CcSEcCtD
Indapamide—Nausea—Fluorouracil—breast cancer	3.23e-05	0.000138	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—breast cancer	3.22e-05	0.000138	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—breast cancer	3.22e-05	0.000138	CcSEcCtD
Indapamide—Gastrointestinal pain—Docetaxel—breast cancer	3.21e-05	0.000138	CcSEcCtD
Indapamide—Anaemia—Methotrexate—breast cancer	3.21e-05	0.000137	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—breast cancer	3.2e-05	0.000137	CcSEcCtD
Indapamide—Flushing—Doxorubicin—breast cancer	3.2e-05	0.000137	CcSEcCtD
Indapamide—Flatulence—Epirubicin—breast cancer	3.2e-05	0.000137	CcSEcCtD
Indapamide—Tension—Epirubicin—breast cancer	3.19e-05	0.000136	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—breast cancer	3.18e-05	0.000136	CcSEcCtD
Indapamide—Diarrhoea—Paclitaxel—breast cancer	3.17e-05	0.000136	CcSEcCtD
Indapamide—Nervousness—Epirubicin—breast cancer	3.15e-05	0.000135	CcSEcCtD
Indapamide—Back pain—Epirubicin—breast cancer	3.14e-05	0.000135	CcSEcCtD
Indapamide—Feeling abnormal—Capecitabine—breast cancer	3.13e-05	0.000134	CcSEcCtD
Indapamide—Malaise—Methotrexate—breast cancer	3.13e-05	0.000134	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—breast cancer	3.12e-05	0.000134	CcSEcCtD
Indapamide—Vertigo—Methotrexate—breast cancer	3.12e-05	0.000134	CcSEcCtD
Indapamide—Gastrointestinal pain—Capecitabine—breast cancer	3.11e-05	0.000133	CcSEcCtD
Indapamide—Abdominal pain—Docetaxel—breast cancer	3.11e-05	0.000133	CcSEcCtD
Indapamide—Body temperature increased—Docetaxel—breast cancer	3.11e-05	0.000133	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—breast cancer	3.11e-05	0.000133	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—breast cancer	3.08e-05	0.000132	CcSEcCtD
Indapamide—Dizziness—Paclitaxel—breast cancer	3.06e-05	0.000131	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—breast cancer	3.06e-05	0.000131	CcSEcCtD
Indapamide—Cough—Methotrexate—breast cancer	3.03e-05	0.00013	CcSEcCtD
Indapamide—Urticaria—Capecitabine—breast cancer	3.02e-05	0.000129	CcSEcCtD
Indapamide—Ill-defined disorder—Epirubicin—breast cancer	3.01e-05	0.000129	CcSEcCtD
Indapamide—Body temperature increased—Capecitabine—breast cancer	3.01e-05	0.000129	CcSEcCtD
Indapamide—Abdominal pain—Capecitabine—breast cancer	3.01e-05	0.000129	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—breast cancer	3e-05	0.000129	CcSEcCtD
Indapamide—Erythema—Doxorubicin—breast cancer	3e-05	0.000129	CcSEcCtD
Indapamide—Anaemia—Epirubicin—breast cancer	3e-05	0.000129	CcSEcCtD
Indapamide—Agitation—Epirubicin—breast cancer	2.98e-05	0.000128	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—breast cancer	2.96e-05	0.000127	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—breast cancer	2.95e-05	0.000127	CcSEcCtD
Indapamide—Myalgia—Methotrexate—breast cancer	2.95e-05	0.000127	CcSEcCtD
Indapamide—Chest pain—Methotrexate—breast cancer	2.95e-05	0.000127	CcSEcCtD
Indapamide—Tension—Doxorubicin—breast cancer	2.95e-05	0.000126	CcSEcCtD
Indapamide—Vomiting—Paclitaxel—breast cancer	2.95e-05	0.000126	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—breast cancer	2.94e-05	0.000126	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.93e-05	0.000126	CcSEcCtD
Indapamide—Malaise—Epirubicin—breast cancer	2.93e-05	0.000125	CcSEcCtD
Indapamide—Rash—Paclitaxel—breast cancer	2.92e-05	0.000125	CcSEcCtD
Indapamide—Dermatitis—Paclitaxel—breast cancer	2.92e-05	0.000125	CcSEcCtD
Indapamide—Discomfort—Methotrexate—breast cancer	2.92e-05	0.000125	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—breast cancer	2.92e-05	0.000125	CcSEcCtD
Indapamide—Vertigo—Epirubicin—breast cancer	2.92e-05	0.000125	CcSEcCtD
Indapamide—Syncope—Epirubicin—breast cancer	2.91e-05	0.000125	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—breast cancer	2.91e-05	0.000124	CcSEcCtD
Indapamide—Back pain—Doxorubicin—breast cancer	2.91e-05	0.000124	CcSEcCtD
Indapamide—Headache—Paclitaxel—breast cancer	2.9e-05	0.000124	CcSEcCtD
Indapamide—Hypersensitivity—Docetaxel—breast cancer	2.89e-05	0.000124	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—breast cancer	2.89e-05	0.000124	CcSEcCtD
Indapamide—Palpitations—Epirubicin—breast cancer	2.87e-05	0.000123	CcSEcCtD
Indapamide—Loss of consciousness—Epirubicin—breast cancer	2.85e-05	0.000122	CcSEcCtD
Indapamide—Cough—Epirubicin—breast cancer	2.83e-05	0.000121	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—breast cancer	2.83e-05	0.000121	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—breast cancer	2.83e-05	0.000121	CcSEcCtD
Indapamide—Asthenia—Docetaxel—breast cancer	2.82e-05	0.000121	CcSEcCtD
Indapamide—Infection—Methotrexate—breast cancer	2.81e-05	0.00012	CcSEcCtD
Indapamide—Hypersensitivity—Capecitabine—breast cancer	2.8e-05	0.00012	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—breast cancer	2.79e-05	0.000119	CcSEcCtD
Indapamide—Pruritus—Docetaxel—breast cancer	2.78e-05	0.000119	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—breast cancer	2.78e-05	0.000119	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—breast cancer	2.78e-05	0.000119	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—breast cancer	2.77e-05	0.000119	CcSEcCtD
Indapamide—Myalgia—Epirubicin—breast cancer	2.76e-05	0.000118	CcSEcCtD
Indapamide—Chest pain—Epirubicin—breast cancer	2.76e-05	0.000118	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—breast cancer	2.76e-05	0.000118	CcSEcCtD
Indapamide—Agitation—Doxorubicin—breast cancer	2.76e-05	0.000118	CcSEcCtD
Indapamide—Anxiety—Epirubicin—breast cancer	2.75e-05	0.000118	CcSEcCtD
Indapamide—Nausea—Paclitaxel—breast cancer	2.75e-05	0.000118	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—breast cancer	2.75e-05	0.000118	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.74e-05	0.000118	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—breast cancer	2.74e-05	0.000117	CcSEcCtD
Indapamide—Discomfort—Epirubicin—breast cancer	2.73e-05	0.000117	CcSEcCtD
Indapamide—Asthenia—Capecitabine—breast cancer	2.73e-05	0.000117	CcSEcCtD
Indapamide—Malaise—Doxorubicin—breast cancer	2.71e-05	0.000116	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—breast cancer	2.7e-05	0.000116	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—breast cancer	2.7e-05	0.000116	CcSEcCtD
Indapamide—Anorexia—Methotrexate—breast cancer	2.7e-05	0.000116	CcSEcCtD
Indapamide—Syncope—Doxorubicin—breast cancer	2.69e-05	0.000115	CcSEcCtD
Indapamide—Pruritus—Capecitabine—breast cancer	2.69e-05	0.000115	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—breast cancer	2.69e-05	0.000115	CcSEcCtD
Indapamide—Diarrhoea—Docetaxel—breast cancer	2.69e-05	0.000115	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—breast cancer	2.65e-05	0.000114	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—breast cancer	2.65e-05	0.000114	CcSEcCtD
Indapamide—Oedema—Epirubicin—breast cancer	2.65e-05	0.000114	CcSEcCtD
Indapamide—Hypotension—Methotrexate—breast cancer	2.65e-05	0.000113	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—breast cancer	2.64e-05	0.000113	CcSEcCtD
Indapamide—Infection—Epirubicin—breast cancer	2.63e-05	0.000113	CcSEcCtD
Indapamide—Cough—Doxorubicin—breast cancer	2.62e-05	0.000112	CcSEcCtD
Indapamide—Shock—Epirubicin—breast cancer	2.61e-05	0.000112	CcSEcCtD
Indapamide—Diarrhoea—Capecitabine—breast cancer	2.6e-05	0.000111	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—breast cancer	2.6e-05	0.000111	CcSEcCtD
Indapamide—Dizziness—Docetaxel—breast cancer	2.6e-05	0.000111	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—breast cancer	2.59e-05	0.000111	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—breast cancer	2.59e-05	0.000111	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—breast cancer	2.58e-05	0.00011	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—breast cancer	2.57e-05	0.00011	CcSEcCtD
Indapamide—Hyperhidrosis—Epirubicin—breast cancer	2.56e-05	0.00011	CcSEcCtD
Indapamide—Insomnia—Methotrexate—breast cancer	2.56e-05	0.00011	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—breast cancer	2.56e-05	0.00011	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—breast cancer	2.56e-05	0.00011	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—breast cancer	2.56e-05	0.00011	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—breast cancer	2.55e-05	0.000109	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—breast cancer	2.54e-05	0.000109	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.54e-05	0.000109	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—breast cancer	2.53e-05	0.000108	CcSEcCtD
Indapamide—Anorexia—Epirubicin—breast cancer	2.53e-05	0.000108	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—breast cancer	2.52e-05	0.000108	CcSEcCtD
Indapamide—Somnolence—Methotrexate—breast cancer	2.52e-05	0.000108	CcSEcCtD
Indapamide—Dizziness—Capecitabine—breast cancer	2.52e-05	0.000108	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—breast cancer	2.5e-05	0.000107	CcSEcCtD
Indapamide—Vomiting—Docetaxel—breast cancer	2.5e-05	0.000107	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—breast cancer	2.49e-05	0.000107	CcSEcCtD
Indapamide—Rash—Docetaxel—breast cancer	2.48e-05	0.000106	CcSEcCtD
Indapamide—Hypotension—Epirubicin—breast cancer	2.48e-05	0.000106	CcSEcCtD
Indapamide—Dermatitis—Docetaxel—breast cancer	2.47e-05	0.000106	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—breast cancer	2.46e-05	0.000105	CcSEcCtD
Indapamide—Headache—Docetaxel—breast cancer	2.46e-05	0.000105	CcSEcCtD
Indapamide—Oedema—Doxorubicin—breast cancer	2.45e-05	0.000105	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—breast cancer	2.45e-05	0.000105	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—breast cancer	2.44e-05	0.000105	CcSEcCtD
Indapamide—Fatigue—Methotrexate—breast cancer	2.44e-05	0.000105	CcSEcCtD
Indapamide—Infection—Doxorubicin—breast cancer	2.44e-05	0.000104	CcSEcCtD
Indapamide—Pain—Methotrexate—breast cancer	2.42e-05	0.000104	CcSEcCtD
Indapamide—Vomiting—Capecitabine—breast cancer	2.42e-05	0.000104	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—breast cancer	2.41e-05	0.000103	CcSEcCtD
Indapamide—Shock—Doxorubicin—breast cancer	2.41e-05	0.000103	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—breast cancer	2.4e-05	0.000103	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—breast cancer	2.4e-05	0.000103	CcSEcCtD
Indapamide—Rash—Capecitabine—breast cancer	2.4e-05	0.000103	CcSEcCtD
Indapamide—Insomnia—Epirubicin—breast cancer	2.4e-05	0.000103	CcSEcCtD
Indapamide—Dermatitis—Capecitabine—breast cancer	2.4e-05	0.000103	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—breast cancer	2.39e-05	0.000102	CcSEcCtD
Indapamide—Headache—Capecitabine—breast cancer	2.38e-05	0.000102	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—breast cancer	2.38e-05	0.000102	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—breast cancer	2.38e-05	0.000102	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—breast cancer	2.37e-05	0.000102	CcSEcCtD
Indapamide—Dyspnoea—Epirubicin—breast cancer	2.36e-05	0.000101	CcSEcCtD
Indapamide—Somnolence—Epirubicin—breast cancer	2.36e-05	0.000101	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—breast cancer	2.34e-05	0.0001	CcSEcCtD
Indapamide—Nausea—Docetaxel—breast cancer	2.33e-05	0.0001	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—breast cancer	2.33e-05	9.99e-05	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—breast cancer	2.33e-05	9.99e-05	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—breast cancer	2.32e-05	9.92e-05	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—breast cancer	2.3e-05	9.87e-05	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—breast cancer	2.29e-05	9.81e-05	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—breast cancer	2.29e-05	9.8e-05	CcSEcCtD
Indapamide—Fatigue—Epirubicin—breast cancer	2.28e-05	9.79e-05	CcSEcCtD
Indapamide—Constipation—Epirubicin—breast cancer	2.27e-05	9.71e-05	CcSEcCtD
Indapamide—Pain—Epirubicin—breast cancer	2.27e-05	9.71e-05	CcSEcCtD
Indapamide—Nausea—Capecitabine—breast cancer	2.26e-05	9.68e-05	CcSEcCtD
Indapamide—Urticaria—Methotrexate—breast cancer	2.25e-05	9.64e-05	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—breast cancer	2.24e-05	9.59e-05	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—breast cancer	2.24e-05	9.59e-05	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.23e-05	9.57e-05	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—breast cancer	2.22e-05	9.5e-05	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—breast cancer	2.2e-05	9.43e-05	CcSEcCtD
Indapamide—Dyspnoea—Doxorubicin—breast cancer	2.19e-05	9.36e-05	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—breast cancer	2.18e-05	9.35e-05	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—breast cancer	2.18e-05	9.34e-05	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—breast cancer	2.17e-05	9.28e-05	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—breast cancer	2.16e-05	9.24e-05	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—breast cancer	2.13e-05	9.13e-05	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—breast cancer	2.12e-05	9.07e-05	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—breast cancer	2.11e-05	9.05e-05	CcSEcCtD
Indapamide—Urticaria—Epirubicin—breast cancer	2.1e-05	9.02e-05	CcSEcCtD
Indapamide—Constipation—Doxorubicin—breast cancer	2.1e-05	8.98e-05	CcSEcCtD
Indapamide—Pain—Doxorubicin—breast cancer	2.1e-05	8.98e-05	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—breast cancer	2.09e-05	8.97e-05	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—breast cancer	2.09e-05	8.97e-05	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—breast cancer	2.09e-05	8.94e-05	CcSEcCtD
Indapamide—CA2—Metabolism—NQO1—breast cancer	2.03e-05	0.000275	CbGpPWpGaD
Indapamide—Asthenia—Methotrexate—breast cancer	2.03e-05	8.7e-05	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—GSTT1—breast cancer	2.03e-05	0.000275	CbGpPWpGaD
Indapamide—Feeling abnormal—Doxorubicin—breast cancer	2.02e-05	8.65e-05	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—breast cancer	2e-05	8.59e-05	CcSEcCtD
Indapamide—Pruritus—Methotrexate—breast cancer	2e-05	8.58e-05	CcSEcCtD
Indapamide—CA4—Metabolism—HSP90AA1—breast cancer	1.99e-05	0.00027	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP3A4—breast cancer	1.98e-05	0.000268	CbGpPWpGaD
Indapamide—Hypersensitivity—Epirubicin—breast cancer	1.95e-05	8.36e-05	CcSEcCtD
Indapamide—CA12—Metabolism—GPX1—breast cancer	1.95e-05	0.000264	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP17A1—breast cancer	1.95e-05	0.000264	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1B1—breast cancer	1.95e-05	0.000264	CbGpPWpGaD
Indapamide—Urticaria—Doxorubicin—breast cancer	1.95e-05	8.34e-05	CcSEcCtD
Indapamide—CA7—Metabolism—MTHFR—breast cancer	1.94e-05	0.000263	CbGpPWpGaD
Indapamide—CA5B—Metabolism—MTHFR—breast cancer	1.94e-05	0.000263	CbGpPWpGaD
Indapamide—Abdominal pain—Doxorubicin—breast cancer	1.94e-05	8.3e-05	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—breast cancer	1.94e-05	8.3e-05	CcSEcCtD
Indapamide—CA4—Metabolism—NCOA1—breast cancer	1.94e-05	0.000263	CbGpPWpGaD
Indapamide—Diarrhoea—Methotrexate—breast cancer	1.94e-05	8.3e-05	CcSEcCtD
Indapamide—CA9—Metabolism—ENO1—breast cancer	1.93e-05	0.000262	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS1—breast cancer	1.93e-05	0.000262	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1A1—breast cancer	1.93e-05	0.000262	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP17A1—breast cancer	1.92e-05	0.00026	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CAV1—breast cancer	1.92e-05	0.00026	CbGpPWpGaD
Indapamide—CA12—Metabolism—ERCC2—breast cancer	1.91e-05	0.000259	CbGpPWpGaD
Indapamide—CA2—Metabolism—HSP90AA1—breast cancer	1.91e-05	0.000259	CbGpPWpGaD
Indapamide—CA4—Metabolism—STK11—breast cancer	1.91e-05	0.000259	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP19A1—breast cancer	1.91e-05	0.000259	CbGpPWpGaD
Indapamide—Asthenia—Epirubicin—breast cancer	1.9e-05	8.14e-05	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—PTGS1—breast cancer	1.9e-05	0.000257	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	1.89e-05	0.000257	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP2D6—breast cancer	1.89e-05	0.000257	CbGpPWpGaD
Indapamide—Pruritus—Epirubicin—breast cancer	1.87e-05	8.03e-05	CcSEcCtD
Indapamide—Dizziness—Methotrexate—breast cancer	1.87e-05	8.02e-05	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—CYP2D6—breast cancer	1.86e-05	0.000253	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOA2—breast cancer	1.86e-05	0.000252	CbGpPWpGaD
Indapamide—CA2—Metabolism—NCOA1—breast cancer	1.86e-05	0.000252	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	1.84e-05	0.000249	CbGpPWpGaD
Indapamide—CA2—Metabolism—STK11—breast cancer	1.83e-05	0.000248	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP19A1—breast cancer	1.83e-05	0.000248	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—NCOA2—breast cancer	1.83e-05	0.000248	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—breast cancer	1.83e-05	0.000248	CbGpPWpGaD
Indapamide—Diarrhoea—Epirubicin—breast cancer	1.81e-05	7.77e-05	CcSEcCtD
Indapamide—Hypersensitivity—Doxorubicin—breast cancer	1.81e-05	7.74e-05	CcSEcCtD
Indapamide—CA9—Metabolism—FASN—breast cancer	1.8e-05	0.000244	CbGpPWpGaD
Indapamide—Vomiting—Methotrexate—breast cancer	1.8e-05	7.71e-05	CcSEcCtD
Indapamide—CA12—Metabolism—MTHFR—breast cancer	1.8e-05	0.000244	CbGpPWpGaD
Indapamide—CA9—Metabolism—BCHE—breast cancer	1.79e-05	0.000243	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CAV1—breast cancer	1.79e-05	0.000243	CbGpPWpGaD
Indapamide—CA7—Metabolism—CAV1—breast cancer	1.79e-05	0.000243	CbGpPWpGaD
Indapamide—Rash—Methotrexate—breast cancer	1.79e-05	7.65e-05	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—breast cancer	1.78e-05	7.64e-05	CcSEcCtD
Indapamide—CA4—Metabolism—COMT—breast cancer	1.78e-05	0.000241	CbGpPWpGaD
Indapamide—Headache—Methotrexate—breast cancer	1.77e-05	7.6e-05	CcSEcCtD
Indapamide—CA9—Metabolism—SLC5A5—breast cancer	1.77e-05	0.00024	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—breast cancer	1.77e-05	0.000239	CbGpPWpGaD
Indapamide—Asthenia—Doxorubicin—breast cancer	1.76e-05	7.53e-05	CcSEcCtD
Indapamide—Dizziness—Epirubicin—breast cancer	1.75e-05	7.51e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—PIK3CG—breast cancer	1.75e-05	0.000237	CbGpPWpGaD
Indapamide—CA4—Metabolism—HMOX1—breast cancer	1.74e-05	0.000236	CbGpPWpGaD
Indapamide—CA4—Metabolism—ITPR1—breast cancer	1.74e-05	0.000236	CbGpPWpGaD
Indapamide—Pruritus—Doxorubicin—breast cancer	1.73e-05	7.43e-05	CcSEcCtD
Indapamide—CA9—Metabolism—NQO1—breast cancer	1.71e-05	0.000232	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC2A1—breast cancer	1.71e-05	0.000232	CbGpPWpGaD
Indapamide—CA2—Metabolism—COMT—breast cancer	1.7e-05	0.000231	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTP1—breast cancer	1.69e-05	0.00023	CbGpPWpGaD
Indapamide—Vomiting—Epirubicin—breast cancer	1.68e-05	7.22e-05	CcSEcCtD
Indapamide—Nausea—Methotrexate—breast cancer	1.68e-05	7.2e-05	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—breast cancer	1.68e-05	7.19e-05	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—IL6—breast cancer	1.67e-05	0.000227	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCB1—breast cancer	1.67e-05	0.000227	CbGpPWpGaD
Indapamide—CA2—Metabolism—HMOX1—breast cancer	1.67e-05	0.000226	CbGpPWpGaD
Indapamide—Rash—Epirubicin—breast cancer	1.67e-05	7.16e-05	CcSEcCtD
Indapamide—CA9—Metabolism—CYP3A4—breast cancer	1.67e-05	0.000226	CbGpPWpGaD
Indapamide—Dermatitis—Epirubicin—breast cancer	1.67e-05	7.15e-05	CcSEcCtD
Indapamide—CA2—Metabolism—ITPR1—breast cancer	1.67e-05	0.000226	CbGpPWpGaD
Indapamide—CA12—Metabolism—CAV1—breast cancer	1.66e-05	0.000225	CbGpPWpGaD
Indapamide—Headache—Epirubicin—breast cancer	1.66e-05	7.11e-05	CcSEcCtD
Indapamide—CA4—Metabolism—TYMS—breast cancer	1.64e-05	0.000223	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1B1—breast cancer	1.64e-05	0.000222	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CG—breast cancer	1.63e-05	0.000221	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CG—breast cancer	1.63e-05	0.000221	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTM1—breast cancer	1.62e-05	0.00022	CbGpPWpGaD
Indapamide—CA4—Metabolism—PLA2G4A—breast cancer	1.62e-05	0.00022	CbGpPWpGaD
Indapamide—CA4—Metabolism—NCOR1—breast cancer	1.62e-05	0.00022	CbGpPWpGaD
Indapamide—Dizziness—Doxorubicin—breast cancer	1.62e-05	6.94e-05	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—CYP1B1—breast cancer	1.62e-05	0.000219	CbGpPWpGaD
Indapamide—CA9—Metabolism—HSP90AA1—breast cancer	1.61e-05	0.000218	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCB1—breast cancer	1.6e-05	0.000217	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	1.59e-05	0.000216	CbGpPWpGaD
Indapamide—CA2—Metabolism—TYMS—breast cancer	1.58e-05	0.000213	CbGpPWpGaD
Indapamide—Nausea—Epirubicin—breast cancer	1.57e-05	6.74e-05	CcSEcCtD
Indapamide—CA9—Metabolism—NCOA1—breast cancer	1.57e-05	0.000212	CbGpPWpGaD
Indapamide—Vomiting—Doxorubicin—breast cancer	1.56e-05	6.68e-05	CcSEcCtD
Indapamide—CA2—Metabolism—PLA2G4A—breast cancer	1.56e-05	0.000211	CbGpPWpGaD
Indapamide—CA2—Metabolism—NCOR1—breast cancer	1.56e-05	0.000211	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTM1—breast cancer	1.56e-05	0.000211	CbGpPWpGaD
Indapamide—CA4—Metabolism—GPX1—breast cancer	1.56e-05	0.000211	CbGpPWpGaD
Indapamide—Rash—Doxorubicin—breast cancer	1.55e-05	6.62e-05	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—breast cancer	1.54e-05	6.62e-05	CcSEcCtD
Indapamide—CA9—Metabolism—CYP19A1—breast cancer	1.54e-05	0.000209	CbGpPWpGaD
Indapamide—CA9—Metabolism—STK11—breast cancer	1.54e-05	0.000209	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—NCOA1—breast cancer	1.54e-05	0.000209	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1A1—breast cancer	1.54e-05	0.000209	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CD—breast cancer	1.54e-05	0.000208	CbGpPWpGaD
Indapamide—Headache—Doxorubicin—breast cancer	1.54e-05	6.58e-05	CcSEcCtD
Indapamide—CA4—Metabolism—ERCC2—breast cancer	1.53e-05	0.000207	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP19A1—breast cancer	1.52e-05	0.000206	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ALB—breast cancer	1.52e-05	0.000206	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CG—breast cancer	1.51e-05	0.000205	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.5e-05	0.000203	CbGpPWpGaD
Indapamide—CA2—Metabolism—GPX1—breast cancer	1.49e-05	0.000202	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1A1—breast cancer	1.48e-05	0.0002	CbGpPWpGaD
Indapamide—CA2—Metabolism—ERCC2—breast cancer	1.46e-05	0.000198	CbGpPWpGaD
Indapamide—Nausea—Doxorubicin—breast cancer	1.46e-05	6.24e-05	CcSEcCtD
Indapamide—CA5A—Metabolism—NOS3—breast cancer	1.45e-05	0.000197	CbGpPWpGaD
Indapamide—CA4—Metabolism—MTHFR—breast cancer	1.44e-05	0.000194	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CD—breast cancer	1.43e-05	0.000194	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CD—breast cancer	1.43e-05	0.000194	CbGpPWpGaD
Indapamide—CA9—Metabolism—COMT—breast cancer	1.43e-05	0.000194	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—breast cancer	1.43e-05	0.000193	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALB—breast cancer	1.42e-05	0.000192	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALB—breast cancer	1.42e-05	0.000192	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—COMT—breast cancer	1.41e-05	0.000191	CbGpPWpGaD
Indapamide—CA9—Metabolism—HMOX1—breast cancer	1.41e-05	0.000191	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.41e-05	0.00019	CbGpPWpGaD
Indapamide—CA9—Metabolism—ITPR1—breast cancer	1.41e-05	0.00019	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.39e-05	0.000189	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.39e-05	0.000188	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTHFR—breast cancer	1.38e-05	0.000186	CbGpPWpGaD
Indapamide—CA7—Metabolism—NOS3—breast cancer	1.36e-05	0.000184	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NOS3—breast cancer	1.36e-05	0.000184	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCB1—breast cancer	1.35e-05	0.000183	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CB—breast cancer	1.34e-05	0.000182	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CD—breast cancer	1.33e-05	0.00018	CbGpPWpGaD
Indapamide—CA9—Metabolism—TYMS—breast cancer	1.33e-05	0.00018	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—breast cancer	1.33e-05	0.00018	CbGpPWpGaD
Indapamide—CA4—Metabolism—CAV1—breast cancer	1.32e-05	0.000179	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTM1—breast cancer	1.31e-05	0.000178	CbGpPWpGaD
Indapamide—CA9—Metabolism—PLA2G4A—breast cancer	1.31e-05	0.000178	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOR1—breast cancer	1.31e-05	0.000178	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALB—breast cancer	1.31e-05	0.000178	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.29e-05	0.000175	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.27e-05	0.000173	CbGpPWpGaD
Indapamide—CA2—Metabolism—CAV1—breast cancer	1.27e-05	0.000172	CbGpPWpGaD
Indapamide—CA9—Metabolism—GPX1—breast cancer	1.26e-05	0.00017	CbGpPWpGaD
Indapamide—CA12—Metabolism—NOS3—breast cancer	1.26e-05	0.00017	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CB—breast cancer	1.25e-05	0.000169	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CB—breast cancer	1.25e-05	0.000169	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1A1—breast cancer	1.24e-05	0.000169	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—breast cancer	1.24e-05	0.000168	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—breast cancer	1.24e-05	0.000168	CbGpPWpGaD
Indapamide—CA9—Metabolism—ERCC2—breast cancer	1.23e-05	0.000167	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.22e-05	0.000166	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.21e-05	0.000164	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CG—breast cancer	1.21e-05	0.000163	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTHFR—breast cancer	1.16e-05	0.000157	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CB—breast cancer	1.16e-05	0.000157	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTEN—breast cancer	1.16e-05	0.000157	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CG—breast cancer	1.16e-05	0.000157	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—breast cancer	1.15e-05	0.000156	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTEN—breast cancer	1.08e-05	0.000146	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTEN—breast cancer	1.08e-05	0.000146	CbGpPWpGaD
Indapamide—CA9—Metabolism—CAV1—breast cancer	1.07e-05	0.000145	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CD—breast cancer	1.06e-05	0.000144	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALB—breast cancer	1.05e-05	0.000142	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CD—breast cancer	1.02e-05	0.000138	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALB—breast cancer	1e-05	0.000136	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTEN—breast cancer	1e-05	0.000136	CbGpPWpGaD
Indapamide—CA4—Metabolism—NOS3—breast cancer	1e-05	0.000136	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SYNJ2—breast cancer	9.85e-06	0.000133	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CG—breast cancer	9.74e-06	0.000132	CbGpPWpGaD
Indapamide—CA2—Metabolism—NOS3—breast cancer	9.6e-06	0.00013	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CB—breast cancer	9.24e-06	0.000125	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NDUFS3—breast cancer	9.16e-06	0.000124	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—breast cancer	9.16e-06	0.000124	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CB—breast cancer	8.86e-06	0.00012	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—breast cancer	8.78e-06	0.000119	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CHST9—breast cancer	8.61e-06	0.000117	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CD—breast cancer	8.57e-06	0.000116	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALB—breast cancer	8.46e-06	0.000115	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—breast cancer	8.17e-06	0.000111	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—COX11—breast cancer	8.16e-06	0.000111	CbGpPWpGaD
Indapamide—CA9—Metabolism—NOS3—breast cancer	8.09e-06	0.00011	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTEN—breast cancer	7.98e-06	0.000108	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTEN—breast cancer	7.66e-06	0.000104	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—breast cancer	7.62e-06	0.000103	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—breast cancer	7.62e-06	0.000103	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CB—breast cancer	7.47e-06	0.000101	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SHMT1—breast cancer	7.47e-06	0.000101	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CDA—breast cancer	7.47e-06	0.000101	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—breast cancer	7.4e-06	0.0001	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLCO1B1—breast cancer	7.19e-06	9.74e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC2A5—breast cancer	7.19e-06	9.74e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—breast cancer	7.06e-06	9.57e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—APRT—breast cancer	6.94e-06	9.41e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—breast cancer	6.67e-06	9.04e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ESRRA—breast cancer	6.53e-06	8.84e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.53e-06	8.84e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTEN—breast cancer	6.45e-06	8.74e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—breast cancer	6.23e-06	8.44e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—breast cancer	6.23e-06	8.44e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HADHB—breast cancer	6.19e-06	8.38e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPI—breast cancer	6.19e-06	8.38e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.9e-06	8e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.9e-06	8e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—breast cancer	5.77e-06	7.82e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PHGDH—breast cancer	5.66e-06	7.67e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UMPS—breast cancer	5.66e-06	7.67e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADSL—breast cancer	5.66e-06	7.67e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NME1—breast cancer	5.66e-06	7.67e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FHL2—breast cancer	5.66e-06	7.67e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—breast cancer	5.63e-06	7.63e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—LDHB—breast cancer	5.55e-06	7.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BRIP1—breast cancer	5.55e-06	7.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HPSE—breast cancer	5.55e-06	7.52e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—breast cancer	5.4e-06	7.32e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA3—breast cancer	5.26e-06	7.13e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HMMR—breast cancer	5.26e-06	7.13e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCC1—breast cancer	5.26e-06	7.13e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.1e-06	6.9e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA9—breast cancer	4.81e-06	6.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA4—breast cancer	4.81e-06	6.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA2—breast cancer	4.69e-06	6.35e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPX2—breast cancer	4.69e-06	6.35e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPX4—breast cancer	4.63e-06	6.28e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SULT1A1—breast cancer	4.63e-06	6.28e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—breast cancer	4.6e-06	6.23e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—breast cancer	4.55e-06	6.17e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—IDH1—breast cancer	4.52e-06	6.13e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA1—breast cancer	4.52e-06	6.13e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NAT2—breast cancer	4.47e-06	6.06e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—breast cancer	4.41e-06	5.98e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—DPYD—breast cancer	3.92e-06	5.31e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MED12—breast cancer	3.92e-06	5.31e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDOA—breast cancer	3.86e-06	5.23e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOA3—breast cancer	3.75e-06	5.08e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC2A2—breast cancer	3.72e-06	5.04e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—breast cancer	3.72e-06	5.04e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CPT1A—breast cancer	3.65e-06	4.94e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCG2—breast cancer	3.65e-06	4.94e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTR—breast cancer	3.65e-06	4.94e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HPGDS—breast cancer	3.58e-06	4.85e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HBA1—breast cancer	3.55e-06	4.81e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—breast cancer	3.47e-06	4.7e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ACHE—breast cancer	3.47e-06	4.7e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP17A1—breast cancer	3.28e-06	4.45e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ENO1—breast cancer	3.25e-06	4.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS1—breast cancer	3.25e-06	4.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2D6—breast cancer	3.19e-06	4.32e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOA2—breast cancer	3.13e-06	4.24e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FASN—breast cancer	3.03e-06	4.11e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BCHE—breast cancer	3.02e-06	4.09e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC5A5—breast cancer	2.98e-06	4.04e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC2A1—breast cancer	2.88e-06	3.91e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NQO1—breast cancer	2.88e-06	3.91e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1B1—breast cancer	2.76e-06	3.74e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.71e-06	3.67e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOA1—breast cancer	2.64e-06	3.57e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—STK11—breast cancer	2.6e-06	3.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP19A1—breast cancer	2.6e-06	3.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—COMT—breast cancer	2.42e-06	3.27e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—breast cancer	2.4e-06	3.26e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HMOX1—breast cancer	2.37e-06	3.21e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ITPR1—breast cancer	2.37e-06	3.21e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCB1—breast cancer	2.28e-06	3.08e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TYMS—breast cancer	2.24e-06	3.03e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.21e-06	2.99e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM1—breast cancer	2.21e-06	2.99e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOR1—breast cancer	2.21e-06	2.99e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPX1—breast cancer	2.12e-06	2.87e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1A1—breast cancer	2.09e-06	2.84e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ERCC2—breast cancer	2.08e-06	2.81e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTHFR—breast cancer	1.95e-06	2.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CAV1—breast cancer	1.8e-06	2.44e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.64e-06	2.22e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.44e-06	1.95e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALB—breast cancer	1.42e-06	1.93e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NOS3—breast cancer	1.36e-06	1.85e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CB—breast cancer	1.26e-06	1.7e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—breast cancer	1.25e-06	1.69e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTEN—breast cancer	1.09e-06	1.47e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—breast cancer	7.66e-07	1.04e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—breast cancer	6.26e-07	8.48e-06	CbGpPWpGaD
